Trial intelligence / Profile preview

Intranasal Insulin Neural Correlates of Memory

NCT02758691Phase 1Completed

Sponsor
Virginia Tech
Start
Dec 2015
Primary completion
Jun 2016
Modality
Recombinant Proteins and Enzymes
01

Overview

Phase 1, randomised, double-blind trial in Alzheimer's disease (AD) comparing Intranasal Insulin with Saline Placebo (2 arms). Primary endpoint: Change in Memory Recall Performance during functional Magnetic Resonance Imaging task at 1 day. Started Dec 2015; status: completed.

02

Drugs

regular human insulin
03

Conditions

Alzheimer's disease (AD)

Beyond the preview

Go deeper on NCT02758691.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02758691.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call